InsidersTradesSigma
Track the Isofol Medical AB (publ) stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Isofol Medical AB (publ) has recorded 6 public disclosures. Market capitalisation: €249.3m. The latest transaction was reported on 15 June 2026 (Purchase). Among the most active insiders: Petter Segelman Lindqvist. All data is openly available.
6
Insider Decl.
n/a
Thresholds
€21,611
5 ops.
Buy Volume
€271
1 ops.
Sell Volume
32Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 June 2026
Declarations6 total
1,000,000 shares@ SEK 0.0923100.0% of flowTeckningsoptionFI:csv-91908161023c21b62fee
7,222 shares@ €0.8550.0025% mcap95.0% of flowBTU (betald tecknad unit)ISIN SE0025197536FI:A003Q438-1
2,412 shares@ €0.8550.0008% mcap88.4% of flowBTU (betald tecknad unit)ISIN SE0025197536FI:A003Q427-1
5,000 shares@ €0.92180.0019% mcap100.0% of flowBTU (betald tecknad unit)ISIN SE0025197536FI:A003Q419-1
90,000 shares@ €0.00360.0001% mcap5.0% of flowTeckningsrätt/UniträttISIN SE0025197528FI:A003Q300-1
33,408 shares@ €0.00810.0001% mcap11.6% of flowTeckningsrätt/UniträttISIN SE0025197528FI:A003Q152-1
6 of 6 declarations
About Isofol Medical AB (publ)
Isofol Medical AB (publ) is a Swedish biopharmaceutical company focused on developing treatments for cancer. It is listed on the Stockholm Stock Exchange (XSTO).